This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Acute fatty liver of pregnancy

Authoring team

  • acute fatty liver of pregnancy has a rapid onset in the third trimester. It has an unknown aetiology
    • there are however case reports revealing a correlation between pregnancy complications such as acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency in the foetus

  • this disease results form accumulation of microvesicular fat in hepatocytes - this condition is associated with potentially rapid onset of liver failure

  • it is rare - 1 in 7000 to 1 in 16000 pregnancies. Note however that a UK study revealed a significantly higher incidence of about 1 in 1,000 pregnancies

  • it is associated with raised bilirubin and transaminase levels; other possible features include hyperuricaemia, thrombocytopaenia and pancreatitis

  • clinical features include vomiting, abdominal pain, and headache. The mother will be jaundiced

  • disease progression may lead to renal failure, clotting disorders and hypoglycaemia

  • treatment involves hospitalisation, immediate delivery, and treatment of liver failure (and renal failure). There is a high maternal and foetal mortality associated with this condition
    • maternal mortality rate has been estimated at 18%, and neonatal mortality rates have ranged from 7% to 58%

Reference:

  1. Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013 Nov;209(5):456.e1-7

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.